Related Articles
Drug resistance analysis of gefitinib-targeted therapy in non-small cell lung cancer
Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung disease
Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy
Gefitinib‑induced interstitial pneumonia: A case report and review of the literature
Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small‑cell lung cancer